Document Detail


Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control.
MedLine Citation:
PMID:  6461238     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ten patients with essential hypertension and left ventricular hypertrophy were treated with relatively small doses of methyldopa (500 to 750 mg/day) added to long-term diuretic therapy. Sequential M mode echocardiography showed significant reduction in left ventricular mass 36 weeks after addition of methyldopa in four patients (359 +/- 77 [standard error of the mean] to 235 +/- 63 g) although blood pressure was not significantly altered by the added treatment. In three of these patients, reduction of left ventricular mass was observed as early as 12 weeks of treatment (384 to 262 g). Neither left ventricular mass to left ventricular volume ratio nor fractional shortening was significantly altered by reduction in left ventricular mass (3.21 +/- 0.26 to 2.74 +/- 0.24 and 0.42 +/- 0.03 to 0.44 +/- 0.02, respectively). There was no apparent relation in these patients between changes in blood pressure and changes in left ventricular mass. Thus, reversal of cardiac hypertrophy with antihypertensive treatment is possible in human beings; however, it seems to depend on other factors besides blood pressure control.
Authors:
F M Fouad; Y Nakashima; R C Tarazi; E E Salcedo
Related Documents :
16601328 - Association between electrocardiographic left ventricular hypertrophy with strain patte...
17101848 - Myocardial injury and ventricular dysfunction related to training levels among nonelite...
8221788 - A stable model of left ventricular dysfunction in an intact animal assessed with high f...
10903348 - Evidence for angiotensin ii type 2 receptor-mediated cardiac myocyte enlargement during...
19054028 - Pulmonary hypertension affects left ventricular basal twist: a novel use for speckle-tr...
18002118 - Continuous ejection fraction estimation by model-based analysis of an aortic pressure w...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  49     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1982 Mar 
Date Detail:
Created Date:  1982-05-21     Completed Date:  1982-05-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  795-801     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure / drug effects*
Cardiac Volume / drug effects
Cardiomegaly / diagnosis,  drug therapy*
Echocardiography
Female
Humans
Hypertension / drug therapy*
Male
Methyldopa / therapeutic use*
Middle Aged
Myocardial Contraction / drug effects
Chemical
Reg. No./Substance:
555-30-6/Methyldopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidenc...
Next Document:  Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic ...